McDermott + Bull has successfully placed Michael Selberis as Chief Technology Officer at ClinNEXUS. Michael will lead the development and execution of ClinNEXUS’s technology strategy, overseeing all aspects of technological direction to ensure alignment with the...
IRVINE, CA (January 7, 2025) – McDermott + Bull, the go-to executive search partner to empower change, is pleased to announce the promotion of Shelby Varon to Managing Director within the firm’s Life Sciences + HealthTech Practice, based in Irvine, California. Shelby...
After a subdued start to the year, PE healthcare services investing in Q3 2024 showed early signs of a rebound. Despite a modest dip in deal volume from Q2, with 148 deals announced or closed, investor confidence is slowly returning. Much of the activity focused on...
What a difference a year makes. In the first half of 2024, the MedTech sector showed a notable uptick in M&A activity, with 114 acquisitions valued at $40.3 billion — close to last year’s total. Despite fewer venture rounds, funding remained strong at $9.7...
McDermott + Bull has successfully placed John Wagner as Chief Executive Officer at private equity-backed Advantage. John will be responsible for providing strategic leadership by collaborating with the Board of Directors, executive management team, and private equity...
McDermott + Bull has successfully placed Lisa Henry as Vice President, Clinical and Regulatory at Magenta Medical. Reporting to the CEO, Lisa will lead the clinical and regulatory strategies critical to Magenta’s success. As the first U.S.-based team member, Lisa will...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
